Menu
Back to Journals » Cancer Management and Research
Cancer Management and Research
ISSN: 1179-1322
Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.
An international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4671)
- Volume 16, 2024 (77)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Latest articles:
- 5 records -
Silencing Exosomal circ102927 Inhibits Foot Melanoma Metastasis via Regulating Invasiveness, Epithelial-Mesenchymal Transition and Apoptosis
Wan H, Zhong L, Xia T, Zhang D
Cancer Management and Research 2024, 16:825-839
Published Date: 15 July 2024
Multimodal Machine Learning-Based Ductal Carcinoma in situ Prediction from Breast Fibromatosis
Jiang Y, Peng Y, Wu Y, Sun Q, Hua T
Cancer Management and Research 2024, 16:811-823
Published Date: 12 July 2024
UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-Making
Baldwin D, Carmichael J, Cook G, Navani N, Peach J, Slater R, Wheatstone P, Wilkins J, Allen-Delingpole N, Kerr CEP, Siddiqui K
Cancer Management and Research 2024, 16:791-810
Published Date: 12 July 2024
Importance of Testing for ROS1 Rearrangements in Non-Small Cell Lung Cancer in the Era of Targeted Therapy in a Latin American Country
Osorio A, Fernandez-Trujillo L, Restrepo JG, Sua LF, Proaño C, Zuñiga-Restrepo V
Cancer Management and Research 2024, 16:781-789
Published Date: 11 July 2024
Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors
Bei W, Dong S, Liu G, Lin L, Jiang Y, Lu N, Li W, Liang H, Xiang Y, Xia W
Cancer Management and Research 2024, 16:771-780
Published Date: 10 July 2024